SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-577773
Filing Date
2016-05-04
Accepted
2016-05-04 16:46:34
Documents
45
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d166732d10q.htm 10-Q 585753
2 EX-10.1 d166732dex101.htm EX-10.1 11638
3 EX-10.2 d166732dex102.htm EX-10.2 84243
4 EX-10.3 d166732dex103.htm EX-10.3 111600
5 EX-31.1 d166732dex311.htm EX-31.1 8910
6 EX-31.2 d166732dex312.htm EX-31.2 8906
7 EX-32.1 d166732dex321.htm EX-32.1 3927
8 EX-32.2 d166732dex322.htm EX-32.2 3960
15 GRAPHIC g166732img001.jpg GRAPHIC 126481
  Complete submission text file 0001193125-16-577773.txt   3472035

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alny-20160331.xml EX-101.INS 526487
10 XBRL TAXONOMY EXTENSION SCHEMA alny-20160331.xsd EX-101.SCH 33341
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20160331_cal.xml EX-101.CAL 51735
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20160331_def.xml EX-101.DEF 192902
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20160331_lab.xml EX-101.LAB 285293
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20160331_pre.xml EX-101.PRE 218666
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 161620100
SIC: 2834 Pharmaceutical Preparations